Though not quite as impressive as Moore’s law growth curve, the type 2 diabetes (T2D) and obesity (referred henceforth as T2DO) treatment market has seen exceptional growth in recent years. ...
The pharmaceutical market aimed at tackling type 2 diabetes (T2D) is vibrant, to say the least. Driven primarily by an increase in global T2D prevalence and a greater market capture of newer (and ...
Since its inception as an academic discipline in 1956, Artificial Intelligence (AI) has enabled significant breakthroughs in the fields of science, healthcare, and transport. While the term ‘AI’ ...
Obesity is a well-established risk factor for the development of type 2 diabetes and the milieu of related metabolic disorders, namely non-alcoholic fatty liver disease and cardiovascular ...
Research drives improvements to frontline healthcare. The evidence it generates is at the core of medical innovations, pathways and treatments. Our brand new Behind the Science feature will ...